These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
217 related items for PubMed ID: 7634397
1. Intestinal metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in rats: Sex difference, inducibility and inhibition by phenethylisothiocyanate. Schulze J, Malone A, Richter E. Carcinogenesis; 1995 Aug; 16(8):1733-40. PubMed ID: 7634397 [Abstract] [Full Text] [Related]
2. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) by hamster, mouse and rat intestine: relevance of species differences. Schulze J, Schläger W, Wünsch R, Richter E. Carcinogenesis; 1996 May; 17(5):1093-9. PubMed ID: 8640918 [Abstract] [Full Text] [Related]
3. Effect of phenethyl isothiocyanate on the metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by cultured rat lung tissue. Doerr-O'Rourke K, Trushin N, Hecht SS, Stoner GD. Carcinogenesis; 1991 Jun; 12(6):1029-34. PubMed ID: 2044181 [Abstract] [Full Text] [Related]
4. The profile of urinary metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in rats is determined by its pulmonary metabolism. Schneider T, Frei E, Wiessler M. Chem Biol Interact; 1999 Apr 15; 118(3):247-66. PubMed ID: 10362230 [Abstract] [Full Text] [Related]
5. Analysis of human urine for pyridine-N-oxide metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco-specific lung carcinogen. Carmella SG, Borukhova A, Akerkar SA, Hecht SS. Cancer Epidemiol Biomarkers Prev; 1997 Feb 15; 6(2):113-20. PubMed ID: 9037562 [Abstract] [Full Text] [Related]
6. Biotransformation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in lung tissue from mouse, rat, hamster, and man. Richter E, Engl J, Friesenegger S, Tricker AR. Chem Res Toxicol; 2009 Jun 15; 22(6):1008-17. PubMed ID: 19408892 [Abstract] [Full Text] [Related]
7. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in isolated rat lung and liver. Schrader E, Hirsch-Ernst KI, Richter E, Foth H. Naunyn Schmiedebergs Arch Pharmacol; 1998 Mar 15; 357(3):336-43. PubMed ID: 9550307 [Abstract] [Full Text] [Related]
10. Effects of long term dietary phenethyl isothiocyanate on the microsomal metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in F344 rats. Staretz ME, Koenig LA, Hecht SS. Carcinogenesis; 1997 Sep 15; 18(9):1715-22. PubMed ID: 9328166 [Abstract] [Full Text] [Related]
11. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in mouse lung microsomes and its inhibition by isothiocyanates. Smith TJ, Guo ZY, Thomas PE, Chung FL, Morse MA, Elkind K, Yang CS. Cancer Res; 1990 Nov 01; 50(21):6817-22. PubMed ID: 2208146 [Abstract] [Full Text] [Related]
12. Effects of phenobarbital and 3-methylcholanthrene induction on the formation of three glucuronide metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, NNK. Murphy SE, Nunes MG, Hatala MA. Chem Biol Interact; 1997 Mar 14; 103(3):153-66. PubMed ID: 9134006 [Abstract] [Full Text] [Related]
13. Use of precision-cut tissue slices in organ culture to study metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) by hamster lung, liver and kidney. Richter E, Friesenegger S, Engl J, Tricker AR. Toxicology; 2000 Apr 03; 144(1-3):83-91. PubMed ID: 10781874 [Abstract] [Full Text] [Related]
14. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by inducible and constitutive cytochrome P450 enzymes in rats. Guo Z, Smith TJ, Thomas PE, Yang CS. Arch Biochem Biophys; 1992 Oct 03; 298(1):279-86. PubMed ID: 1524438 [Abstract] [Full Text] [Related]
15. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in human kidney epithelial cells transfected with rat CYP2B1 cDNA. Lacroix D, Desrochers M, Castonguay A, Anderson A. Carcinogenesis; 1993 Aug 03; 14(8):1639-42. PubMed ID: 8353848 [Abstract] [Full Text] [Related]
17. Quantitation of pyridylhydroxybutyl-DNA adducts in liver and lung of F-344 rats treated with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and enantiomers of its metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol. Upadhyaya P, Kalscheuer S, Hochalter JB, Villalta PW, Hecht SS. Chem Res Toxicol; 2008 Jul 03; 21(7):1468-76. PubMed ID: 18570389 [Abstract] [Full Text] [Related]
18. Human cervical tissue metabolizes the tobacco-specific nitrosamine, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, via alpha-hydroxylation and carbonyl reduction pathways. Prokopczyk B, Trushin N, Leszczynska J, Waggoner SE, El-Bayoumy K. Carcinogenesis; 2001 Jan 03; 22(1):107-14. PubMed ID: 11159748 [Abstract] [Full Text] [Related]
19. Metabolism of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) by human cytochrome P450 1A2 and its inhibition by phenethyl isothiocyanate. Smith TJ, Guo Z, Guengerich FP, Yang CS. Carcinogenesis; 1996 Apr 03; 17(4):809-13. PubMed ID: 8625495 [Abstract] [Full Text] [Related]
20. Analysis of pyridyloxobutyl and pyridylhydroxybutyl DNA adducts in extrahepatic tissues of F344 rats treated chronically with 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and enantiomers of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol. Zhang S, Wang M, Villalta PW, Lindgren BR, Upadhyaya P, Lao Y, Hecht SS. Chem Res Toxicol; 2009 May 03; 22(5):926-36. PubMed ID: 19358518 [Abstract] [Full Text] [Related] Page: [Next] [New Search]